The dawn of OSL, page-17

Also and I think most importantly they have only Really been able to sell outside of New Zealand for the first time ever the quarter we are currently in. They have been able to sell in New Zealand for 2 quarters and achieved 3 sales the first quarter and 2 the following. Considering all of New Zealand population is 4 odd million that’s pretty good. Also the times they are achieving these initial sales in I think is very impressive, they are not selling Lolly pops, it’s a radioactive cancer treatment. Getting sales within 3 months in a newly approved area is very good. If they achieve the same results in the UK by population that’s 15 sales a quarter then the yearly sales from ONLY these 2 relatively small regions is up around 80 doses or a revenue of 2.4 million which equates to about 3.5% of their current market cap. The share will triple from where it is now if the above outcome occurs. I just keep topping up.